These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
486 related articles for article (PubMed ID: 16884455)
21. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial. Peltola J; Coetzee C; Jiménez F; Litovchenko T; Ramaratnam S; Zaslavaskiy L; Lu ZS; Sykes DM; Epilepsia; 2009 Mar; 50(3):406-14. PubMed ID: 19317886 [TBL] [Abstract][Full Text] [Related]
22. Morphine, gabapentin, or their combination for neuropathic pain. Gilron I; Bailey JM; Tu D; Holden RR; Weaver DF; Houlden RL N Engl J Med; 2005 Mar; 352(13):1324-34. PubMed ID: 15800228 [TBL] [Abstract][Full Text] [Related]
23. Gabapentin as add-on therapy in children with refractory partial seizures: a 12-week, multicentre, double-blind, placebo-controlled study. Gabapentin Paediatric Study Group. Appleton R; Fichtner K; LaMoreaux L; Alexander J; Halsall G; Murray G; Garofalo E Epilepsia; 1999 Aug; 40(8):1147-54. PubMed ID: 10448830 [TBL] [Abstract][Full Text] [Related]
24. A double-blind evaluation of gabapentin on alcohol effects and drinking in a clinical laboratory paradigm. Myrick H; Anton R; Voronin K; Wang W; Henderson S Alcohol Clin Exp Res; 2007 Feb; 31(2):221-7. PubMed ID: 17250613 [TBL] [Abstract][Full Text] [Related]
25. Rufinamide for the adjunctive treatment of partial seizures in adults and adolescents: a randomized placebo-controlled trial. Brodie MJ; Rosenfeld WE; Vazquez B; Sachdeo R; Perdomo C; Mann A; Arroyo S Epilepsia; 2009 Aug; 50(8):1899-909. PubMed ID: 19490053 [TBL] [Abstract][Full Text] [Related]
26. Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsy. French JA; Abou-Khalil BW; Leroy RF; Yacubian EM; Shin P; Hall S; Mansbach H; Nohria V; Neurology; 2011 May; 76(18):1555-63. PubMed ID: 21451152 [TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of gabapentin as an add-on therapy in refractory partial epileptic patients. Towanabut S; Rungreangyingyod L; Suthisisang C J Med Assoc Thai; 2001 Apr; 84(4):554-61. PubMed ID: 11460968 [TBL] [Abstract][Full Text] [Related]
28. A gastroretentive gabapentin formulation for the treatment of painful diabetic peripheral neuropathy: efficacy and tolerability in a double-blind, randomized, controlled clinical trial. Sandercock D; Cramer M; Biton V; Cowles VE Diabetes Res Clin Pract; 2012 Sep; 97(3):438-45. PubMed ID: 22497967 [TBL] [Abstract][Full Text] [Related]
29. Efficacy of gabapentin as adjunctive therapy in a large, multicenter study. The Steps Study Group. Morrell MJ; McLean MJ; Willmore LJ; Privitera MD; Faught RE; Holmes GL; Magnus L; Bernstein P; Rose-Legatt Seizure; 2000 Jun; 9(4):241-8. PubMed ID: 10880282 [TBL] [Abstract][Full Text] [Related]